Download PDF

Other users also viewed these articles

Assessment of Metabolic dysfunction-associated steatotic liver disease, Alcohol-associated liver disease, and Metabolic dysfunction and alcohol-associated steatotic liver disease in open Mexican population Jorge Emilio Lira-Vera; Ángel Daniel-Santana Vargas; Gabriela Gutiérrez-Reyes; Oscar Morales-Gutiérrez; María de Fátima Higuera-de la Tijera; Diana Montemira-Orozco; Christian Hinojosa-Segura; Moisés Martínez-Castillo; Samantha Sánchez-Valle; María de los Ángeles Lemus-Peña; Daniel Montes de Oca-Ángeles; Abigail Hernández-Barragán; Marisela Hernández-Santillán; Y.L. Béjar-Ramírez; José Luis Pérez-Hernández;
10.1016/j.aohep.2025.102149
The Toulouse algorithm identifies patients with increased risk of cardiac decompensation only in patients with TIPS for refractory ascites Emma Vanderschueren; Youri Bekhuis; Jan Clerick; Jappe Decock; Philippe Meersseman; Alexander Wilmer; Eveline Claus; Lawrence Bonne; Guido Claessen; Chris Verslype; Geert Maleux; Wim Laleman;
10.1016/j.aohep.2024.101568
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later? Raffaele Brustia; Mohamed Bouattour; Manon Allaire; Marie Lequoy; Clémence Hollande; Hélène Regnault; Lorraine Blaise; Nathalie Ganne-Carrié; Valérie Vilgrain; Edouard Larrey; Chetana Lim; Olivier Scatton; Sanaa El Mouhadi; Violaine Ozenne; François Paye; Pierre Balladur; Anthony Dohan; Pierre-Philippe Massault; Stanislas Pol; Marco Dioguardi Burgio; Ailton Sepulveda; Francois Cauchy; Alain Luciani; Daniele Sommacale; Vincent Leroy; Julien Calderaro; Francoise Roudot-Thoraval; Jean-Charles Nault; Giuliana Amaddeo;
Ann Hepatol. 2023;28: